AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Oct 01 2020
News
Coronavirus vaccine trial participants report day-long exhaustion, fever and headaches — but say it’s worth it
Luke Hutchison woke up in the middle of the night with chills and a fever after taking the Covid-19 booster shot in Moderna’s vaccine trial. Another coronavirus vaccine trial participant, testing Pfizer’s candidate, similarly woke up with chills, shaking so hard he cracked a tooth after taking the second dose.
High fever, body aches, bad headaches and exhaustion are just some of the
CNBCJun 08 2022
News
Novavax Covid vaccine clears key step on path to FDA authorization after committee endorses the shot
Novavax’s two-dose Covid-19 vaccine for adults ages 18 and older cleared a key step on the path toward Food and Drug Administration authorization on Tuesday.
The FDA’s committee of independent vaccine experts voted 21 to 0 with one abstention at the end of an all-day meeting to recommend authorizing the shot for use in the U.S. after an all-day public meeting in which it weighed safety
CNBCNov 18 2020
Opinion
The Latest Vaccine News Doesn’t Tell the Full Story
The drugmakers Moderna and Pfizer buoyed hopes for an end to the coronavirus pandemic when they announced this month that their vaccines were 94.5 percent (Moderna) and 90 percent (Pfizer) effective at preventing Covid-19, based on preliminary results from ongoing clinical trials. Neither vaccine produced any serious safety concerns.
Pfizer’s and Moderna’s data were analyzed by
New York Times (Opinion)Apr 16 2021
News
J&J Privately Asked Rival Covid-19 Vaccine Makers to Probe Clotting Risks
Johnson & Johnson privately reached out to Covid-19 vaccine rivals to ask them to join an effort to study the risks of blood clots and speak with one voice about safety, but Pfizer Inc. and Moderna Inc. declined.
As concerns mounted last week over rare cases of blood clots, J&J asked AstraZeneca PLC as well as Pfizer and Moderna to join its efforts looking into the reports,
Wall Street Journal (News)Apr 10 2021
Analysis
Women report more side effects from the COVID-19 vaccine than men. Health experts explain why.
Reports of COVID-19 vaccine side effects support what many have anecdotally observed: women shoulder the bigger burden.
Among nearly 7,000 reports processed through the Centers for Disease Control and Prevention's Vaccine Adverse Event Reporting System (VAERS) from Dec. 14 to Jan. 13, more than 79% of them came from women. The most frequently reported side effects were headache, fatigue
USA TODAYJun 27 2022
Analysis
Analysis: The next COVID booster shots will likely be updated for Omicron
NEW YORK, June 24 (Reuters) - COVID-19 vaccines this fall are likely to be based on the Omicron variant of the coronavirus rather than the original strain, although some experts suggest they may only offer significant benefits for older and immunocompromised people.
Moderna (MRNA.O), Pfizer (PFE.N) and Novavax (NVAX.O) have been testing vaccines based on the first BA.1 Omicron variant
ReutersFeb 11 2021
News
COVID-19 vaccines: What you need to know about side effects and risks
More than 40 million doses of either the Pfizer or Moderna COVID-19 vaccines have been administered in the United States, mostly to seniors and healthcare workers, since the rollout began in mid-December.
With the growing number of immunizations comes a clearer picture of the negative side effects associated with the shots.
The Moderna and Pfizer vaccines, the only ones
Washington ExaminerNov 17 2020
News
Fauci: Vaccine Results Are 'Important Advance,' But Virus Precautions Are Still Vital
Dr. Anthony Fauci, the country's foremost infectious disease expert, tells NPR that it's "OK to celebrate" the good news about Moderna's coronavirus vaccine, but warned it's not the time to back off on basic health measures.
The biotechnology Moderna Inc. said Monday that its experimental vaccine was 94.5% effective in preventing the disease, according to data from its clinical trial.
NPR (Online News)Oct 13 2022
Analysis
Now CDC approves Omicron booster jab for children as young as FIVE — but even adults don't want it
Children as young as five are to be offered the bivalent Covid booster vaccine ahead of the winter.
The Centers for Disease Control and Prevention (CDC) has recommended five to 11-year-olds get a single dose of Pfizer's updated shot.
Children aged six and above can get Moderna's bivalent booster. Both new vaccines offer better protection against the new Omicron variants than
Daily MailAug 18 2021
News
People with both COVID-19 shots are fully vaccinated without booster, surgeon general says
Surgeon General Vivek Murthy said Wednesday that people who received two Moderna or Pfizer shots are considered fully vaccinated against the coronavirus, even though federal officials will encourage third shots to bolster immunity to the disease.
Washington Examiner